Article Results (Showing 1 - 10 of 32) RSS Alert
» Did you mean: Joseph E Daniel?
-
Surgical Neuropathology Update: A Review of Changes Introduced by the WHO Classification of Tumours of the Central Nervous System, 4th Edition
* Context.-The World Health Organization (WHO) recently published its 4th edition of the classification of tumors of the central nervous system,...
Archives of Pathology & Laboratory Medicine, 06/01/08 by Brat, Daniel J; Parisi, Joseph E; Kleinschmidt-DeMasters, Bette K; Yachnis, Anthony T; Montine, Thomas J; Boyer, Philip J; Powell, Suzanne Z; Prayson, Richard A; McLendon, Roger E · More from publication -
Protocol for the Examination of Specimens From Patients With Tumors of the Brain/Spinal Cord
The College of American Pathologists offers these protocols to assist pathologists in providing clinically useful and relevant information when...
Archives of Pathology & Laboratory Medicine, 06/01/08 by Parisi, Joseph E; Miller, Dylan V; Boyer, Philip J; Brat, Daniel J; Cochran, Elizabeth J; Cohen, Mark L; DeMasters, Bette K; Dolinak, David; McComb, Rodney D; McLendon, Roger E; Powell, Suzanne Z; Prayson, Richard A; Vinters, Harry V; Yachnis, Anthony T · More from publication -
Ingested Fat Oxidation Contributes 8% of 24-h Total Energy Expenditure in Moderately Obese Subjects1,2

ABSTRACT The role of ingested fat in the etiology of obesity is controversial. The aims of this study were to determine the contributions of...
Journal of Nutrition, The, 09/01/05 by Sonko, Bakary J; Fennessey, Paul V; Donnelly, Joseph E; Bessesen, Daniel; Et al · More from publication -
Evaluation of Commercially Available Fluid-Warming Devices for Use in Forward Surgical and Combat Areas
The fluid-warming capabilities of four individual fluid warmers, i.e., Level 1, FMS 2000, Thermal Angel, and Ranger, were compared to evaluate...
Military Medicine, 01/01/05 by Dubick, Michael A; Brooks, Daniel E; Macaitis, Joseph M; Bice, Terry G; Et al · More from publication -
Making regulatory compliance a core process

FDA is no longer complacent, punishing noncompliant companies with puny fines, those small slaps at the financial bottom line. FDA's thunder now...
Biopharm, 08/01/02 by Arling, Edward R; Dillon, Ralph L; Worden, Daniel E; Noferi, Joseph F · More from publication -
Beyond QSIT

If a process is out of control, an FDA inspector will find it, eventually. Companies that emerge as winners will be those that embrace compliance...
Biopharm, 04/01/02 by Arling, Edward R; Worden, Daniel E; Noferi, Joseph F · More from publication -
21 CFR part 11: (Un)expected added value

Regulatory Issues Implementing the ERES rule will do more than make your organization compliant with federal regulations. It will strengthen its...
Biopharm, 02/01/02 by Dillon, Ralph; Worden, Daniel E; Noferi, Joseph F · More from publication -
Information age audits

Process Development Understanding the reach of 21 CFR Part 11 is the first step to assessing its impact. To protect your company, you need...
Biopharm, 01/01/02 by Arling, Edward R; Worden, Daniel E; Noferi, Joseph F · More from publication -
Pathologic quiz case: A large abdominal mass in an otherwise healthy 31-year-old man
31-year-old African American man presented with a chief complaint of abdominal pain for the previous 9 months. He also complained of distention and...
Archives of Pathology & Laboratory Medicine, 12/01/00 by Smith, Michael E; Pelletier, Joseph P; Daniels, Rohini · More from publication -
A cold-gas spray coating process for enhancing titanium
Editor's Note: This paper was presented at the 1998 IS Annual Meeting as part of the Innovations in Titanium symposium, which was sponsored by the...
JOM, 09/01/98 by Segall, Albert E; Papyrin, Anatoli N; Conway, Joseph C Jr; Shapiro, Daniel · More from publication



